New stomach bug treatment shows promise in 14-Day trial
NCT ID NCT06682533
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at how well a 14-day course of tegoprazan (a stomach acid reducer) combined with two antibiotics works to clear H. pylori infection. About 200 adults who need a stomach scope will take the treatment, and researchers will check if the bacteria are gone using a breath test. The goal is to see if this approach is effective and tolerable, especially when adding bismuth to boost success rates.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for H.PYLORI INFECTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Digestive Disease Center, Soonchunhyang University Hospital
RECRUITINGSeoul, 04401, South Korea
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New Two-Drug combo shows promise against stomach bug
- Which test is better for detecting h. pylori?
- Stomach bug treatment may lower bleeding risk for heart patients
- Scientists map h. Pylori's resistance to antibiotics
- Argon plasma zaps stomach bugs in new trial
- Can a daily yogurt beat stomach bugs in kids?